A clinical trial of nalidixic acid (Negram, WIN. 18,320) in thirty-three patients with urinary infections treated in general practice.
D000890:Anti-Infective Agents; D004927:Escherichia coli Infections; D058006:General Practice; D009268:Nalidixic Acid; D009287:Naphthyridines; D011512:Proteus Infections; D014552:Urinary Tract Infections
D000890:Anti-Infective Agents; D009287:Naphthyridines; D009268:Nalidixic Acid
ANTI-INFECTIVE AGENTS; ESCHERICHIA COLI INFECTIONS; NAPHTHYRIDINES; PROTEUS INFECTIONS; URINARY TRACT INFECTIONS